N-terminal pro-brain natriuretic peptide reflects pulmonary capillary leakage in patients with acute dyspnea
References (6)
- et al.
Diagnosis of left-ventricular dysfunction from induced sputum examination
Lancet
(1999) - et al.
Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath
J Am Coll Cardiol
(2003) - et al.
Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
N Engl J Med
(2002)
There are more references available in the full text version of this article.
Cited by (14)
B-Type Natriuretic Peptide, Aldosterone, and Fluid Management in ARDS
2016, ChestCitation Excerpt :Diagnostic utility was limited by unexpectedly high levels of BNP in patients with ARDS,17,19 the etiology of which remains incompletely understood. Although ARDS is classically characterized by normal or low left-sided intravascular pressures,20 up to one-third of patients demonstrate elevated pulmonary capillary wedge pressure,4 and whether BNP elevation arises from left ventricular dysfunction and pressure elevation,21,22 right ventricular strain,7,10,16 or an unrelated mechanism23-27 remains unclear. Whether plasma BNP can be used to guide fluid management in ARDS, as it can in heart failure, has never to our knowledge been studied.
Importance of BNP measurement in intensive care
2007, Praticien en Anesthesie ReanimationHemosiderin-laden macrophages count in sputum in diagnosis of dyspnea of heart origin
2005, Medicina ClinicaHemosiderophages in respiratory secretions. Biological significance and clinical utility
2005, Medicina ClinicaB-type natriuretic peptide: Issues for the intensivist and pulmonologist
2005, Critical Care Medicine
Copyright © 2004 Excerpta Medica Inc. All rights reserved.